Conceptual study about var?a and its experimental evaluation through trial drug in the management of svitra (Vitiligo).

“Study of Ayurvedic Biology of tvaka var?a AND Preclinical and Clinical evaluation of NIA/KS/2022-01 in the management of svitra (VITILIGO) ?.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043876

Enrollment

Registered

2022-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with classical sign and symptoms of svitra.

Exclusion criteria

Exclusion criteria: 1.Known case of any other severe Skin Disorder, Chronic systemic diseases, lesion with oozing and any other allergic skin disorder. 2.Taking any other medication like corticosteroids, immunosuppressant or antibiotics for the same illness. 3.White spots by trauma and burn. 4.More than 70% de-pigmented areas are excluded. 5.Pregnancy and Lactations. 6.Unable to sign consent form.

Design outcomes

Primary

Measure	Time frame
Assessments of trial drug on decrease in VETI score in the management of svitra (Vitiligo). Timepoint: 12 weeks	—

Secondary

Measure	Time frame
Assessment of efficacy of trial drug on color change in the management of svitra (Vitiligo). Assessments of trial drug on relief in classical sign and symptoms of svitra (Vitiligo). Timepoint: 40 weeks	—

Countries

India

Contacts

Public ContactDr Chudasama Hardik

National Institute of Ayurveda, Jaipur

dr.yadavcr@gmail.com9460866101

Outcome results